VIGL NASDAQ
Vigil Neuroscience, Inc.
1W: -0.1%
1M: +0.8%
3M: +178.6%
1Y: +100.8%
3Y: +21.1%
$8.05
Last traded 2025-08-05 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$453K
-13.5% ▼
Operating Income
-$90M
-0.9% ▼
Net Income
-$84M
-2.0% ▼
EPS (Diluted)
$-2.07
+2.8% ▲
EBITDA
-$84M
+5.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $345K | $1M | $399K | $453K |
| Gross Profit | $0 | -$345K | -$1M | -$399K | -$453K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $5M | $32M | $47M | $61M | $62M |
| SG&A Expenses | $2M | $10M | $21M | $28M | $27M |
| Operating Expenses | $6M | $42M | $69M | $89M | $89M |
| Operating Income | -$6M | -$42M | -$69M | -$89M | -$90M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$29M | -$43M | -$68M | -$83M | -$84M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$29M | -$43M | -$68M | -$83M | -$84M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.01 | $-1.57 | $-2.16 | $-2.13 | $-2.07 |
| EBITDA | -$29M | -$42M | -$68M | -$88M | -$84M |
| Shares Outstanding | 28M | 27M | 32M | 39M | 41M |